id	submitter_id	entity_type	entity_id	category	classification	created_datetime	status	notes
7490462b-7c44-4f28-95fa-9accecd3448b	\N	masked_somatic_mutation	d905dd76-e049-415f-bff0-d3d191e25973	General	Notification	2022-02-28T16:16:17.039345-06:00	Approved	Variants from SomaticSniper are not included.
fec99270-88e0-4ceb-9df9-8876093819ac	\N	annotated_somatic_mutation	c29c1cf8-b854-4013-ba79-340966998411	General	Notification	2022-02-28T04:44:55.231971-06:00	Approved	Real somatic mutations were mistakenly labeled as LOH (Loss of Heterozygosity) in certain SomaticSniper VCF files.
a52901e1-aa8c-44c1-af02-07adcef90000	\N	simple_somatic_mutation	60149f7f-6b09-4896-8441-bacd7ecbd101	General	Notification	2022-02-28T04:44:54.045939-06:00	Approved	Real somatic mutations were mistakenly labeled as LOH (Loss of Heterozygosity) in certain SomaticSniper VCF files.
6c712cc3-1db3-5cc5-81f6-61bebd0b9cc7	20730	case	b7cd3b44-ef6a-4207-a44f-14f5b3b56ed4	Case submitted is found to be a recurrence after submission	Notification	2014-06-16T00:00:00	Approved	patient had a prior lower grade glioma
cc467c62-a00d-5689-a47c-181ca1524dbb	3416	case	b7cd3b44-ef6a-4207-a44f-14f5b3b56ed4	Item does not meet study protocol	Notification	2011-10-10T00:00:00	Approved	[intgen.org]: Sample sent to TCGA was not the primary tumor. The initial surgery was a biopsy only with a diagnosis of a grade II oligodendroglioma where tumor was not completely removed. The patient did not receive any pharmaceutical or radiation therapy. Sample submitted was a progression of the tumor to a grade III oligodendroglioma